Simulations Plus, Inc. SLP
Simulations Plus, Inc. was incorporated in California on July 17, 1996. The Company is a global leader and premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery and development, clinical trial operations, and commercialization. The Company supports its clients across the drug development lifecycle from early discovery through all phases of clinical research and development ("R&D"), including clinical operations, to product commercialization. The Company serves clients as a strategic partner throughout the entire drug development lifecycle, offering solutions that integrate scientific software platforms, artificial intelligence-augmented insights, and expert consulting. This optimizes efficiency, costs, and time-to-market for our clients, thereby enhancing our competitive position.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79.2M | $70.0M | $59.6M | $53.9M | $46.5M | $41.6M | $34.0M | $29.7M | $24.1M | $20.0M |
| Cost of revenue | $33.0M | $26.9M | $11.6M | $10.8M | $10.6M | $10.6M | $9.0M | $8.0M | $6.3M | $4.6M |
| Gross profit | $46.2M | $43.2M | $47.9M | $43.1M | $35.9M | $30.9M | $24.9M | $21.7M | $17.8M | $15.4M |
| R&D | $6.9M | $5.8M | $4.5M | $3.2M | $4.0M | $3.0M | $2.5M | $1.8M | $1.4M | $1.4M |
| SG&A | $20.9M | $22.4M | $27.7M | $20.1M | $20.6M | $16.4M | $11.8M | $9.6M | $8.2M | $6.7M |
| Total operating expenses | $117.0M | $37.0M | $39.2M | $28.2M | $24.6M | $19.3M | $14.3M | $11.4M | $9.6M | $8.1M |
| Operating income | -$70.7M | $6.1M | $8.7M | $14.9M | $11.3M | $11.6M | $10.6M | $10.3M | $8.3M | $7.2M |
| Interest expense | — | — | — | — | $22.0K | $0 | $0 | $153.0K | $38.2K | $0 |
| Pre-tax income | -$69.4M | $12.4M | $11.7M | $15.1M | $11.1M | $11.4M | $10.6M | $10.1M | $8.2M | $7.2M |
| Income tax | $4.7M | $2.5M | $1.7M | $2.6M | $1.3M | $2.1M | $2.0M | $1.2M | $2.5M | $2.3M |
| Net income | -$64.7M | $10.0M | $10.0M | $12.5M | $9.8M | $9.3M | $8.6M | $8.9M | $5.8M | $5.0M |
| EPS, basic | -3.22 | 0.50 | 0.50 | 0.62 | 0.49 | 0.52 | 0.49 | 0.52 | 0.34 | 0.29 |
| EPS, diluted | -3.22 | 0.49 | 0.49 | 0.60 | 0.47 | 0.50 | 0.48 | 0.50 | 0.33 | 0.29 |
| Shares, diluted (wtd. avg.) | $20.1M | $20.3M | $20.5M | $20.7M | $20.7M | $18.5M | $18.1M | $17.9M | $17.5M | $17.2M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $30.9M | $10.3M | $57.5M | $51.6M | $37.0M | $49.2M | $11.4M | $9.4M | $6.2M | $8.0M |
| Short-term investments | $1.5M | $9.9M | $57.9M | $76.7M | $86.6M | $66.8M | $0 | — | — | — |
| Receivables | $9.7M | $9.1M | $10.2M | $13.8M | $9.9M | $7.4M | $5.0M | $5.5M | $4.0M | $3.0M |
| Total current assets | $51.5M | $39.3M | $130.4M | $146.8M | $139.3M | $129.1M | $21.2M | $17.8M | $12.7M | $12.7M |
| Property, plant and equipment | $880.0K | $812.0K | $671.0K | $632.0K | $1.8M | $438.0K | $341.1K | $335.2K | $291.1K | $256.4K |
| Goodwill | $43.7M | $96.1M | $19.1M | $12.9M | $12.9M | $12.9M | $10.4M | $10.4M | $10.4M | $4.8M |
| Other intangibles | — | — | — | — | $10.5M | $11.9M | $5.0M | $5.9M | $6.8M | $4.7M |
| Total assets | $131.9M | $196.6M | $186.1M | $188.4M | $180.0M | $168.4M | $45.2M | $43.3M | $38.5M | $27.8M |
| Accounts payable | $470.0K | $602.0K | $144.0K | $225.0K | $387.0K | $351.0K | $204.1K | $351.6K | $240.9K | $108.1K |
| Short-term debt | — | — | — | — | — | — | — | $2.6M | $247.3K | — |
| Total current liabilities | $6.7M | $12.1M | $12.0M | $7.7M | $11.6M | $5.5M | $4.8M | $4.8M | $2.0M | $2.1M |
| Long-term debt | — | — | — | — | — | — | — | $3.3M | $5.7M | — |
| Total liabilities | $7.1M | $14.2M | $16.1M | $10.1M | $14.2M | $12.4M | $7.5M | $11.4M | $12.7M | $5.1M |
| Retained earnings | -$34.4M | $30.4M | $25.2M | $40.0M | $32.4M | $27.4M | $22.4M | $18.5M | $13.7M | $11.3M |
| Total equity | $124.8M | $182.4M | $170.0M | $178.2M | $165.8M | $156.0M | $37.7M | $31.9M | $25.8M | $22.7M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.1M | $13.3M | $21.9M | $17.9M | $19.2M | $10.9M | $11.6M | $9.3M | $6.9M | $5.4M |
| Depreciation and amortisation | $300.0K | $300.0K | $200.0K | $300.0K | $200.0K | $200.0K | $132.0K | $139.2K | $2.1M | $1.9M |
| Stock-based compensation | $6.4M | $6.5M | $4.8M | $3.0M | $2.8M | $1.6M | $1.1M | $709.1K | $621.8K | $347.1K |
| Capital expenditure | $713.0K | $566.0K | $453.0K | $819.0K | $1.6M | $231.0K | $138.0K | $183.3K | $176.0K | $39.1K |
| Investing cash flow | $3.6M | -$54.0M | $7.4M | $4.3M | -$26.7M | -$75.5M | -$2.0M | -$2.3M | -$4.4M | -$2.0M |
| Financing cash flow | -$1.1M | -$6.6M | -$23.3M | -$7.6M | -$4.7M | $102.4M | -$7.6M | -$3.8M | -$4.3M | -$4.0M |
| Dividends paid | $0 | $4.8M | $4.8M | $4.8M | $4.8M | $4.2M | $4.2M | $4.2M | $3.4M | $3.4M |
| Buybacks | $0 | $0 | $20.0M | $0 | $0 | — | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001023459-25-000060.
Others in SIC 7373
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| IOT | Samsara Inc. | $23.39B | — | 29.6% |
| LDOS | Leidos Holdings, Inc. | $16.70B | 11.9x | 3.2% |
| IONQ | IonQ, Inc. | $15.06B | — | 201.9% |
| CACI | CACI INTERNATIONAL INC /DE/ | $13.78B | 25.8x | 10.9% |
| GDDY | GoDaddy Inc. | $12.83B | 16.3x | 8.3% |
| AUR | Aurora Innovation, Inc. | $12.53B | — | — |
| JKHY | JACK HENRY & ASSOCIATES INC | $11.61B | 23.7x | 7.1% |
| OTEX | OPEN TEXT CORP | $5.80B | 9.3x | 1.5% |